These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 23246393)

  • 41. Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen.
    Douketis JD; Johnson JA; Turpie AG
    Arch Intern Med; 2004 Jun; 164(12):1319-26. PubMed ID: 15226166
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Extracardiac Fontan operation after late bidirectional Glenn shunt.
    Ganigara M; Prabhu A; Varghese R; Pavithran S; Valliatu J; Nair RS
    Asian Cardiovasc Thorac Ann; 2010 Jun; 18(3):253-9. PubMed ID: 20519294
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A retrospective review of 61 patients with antiphospholipid syndrome. Analysis of factors influencing recurrent thrombosis.
    Krnic-Barrie S; O'Connor CR; Looney SW; Pierangeli SS; Harris EN
    Arch Intern Med; 1997 Oct; 157(18):2101-8. PubMed ID: 9382667
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Anticoagulation and incidence of late cerebrovascular accidents following the Fontan procedure.
    Mahnke CB; Boyle GJ; Janosky JE; Siewers RD; Pigula FA
    Pediatr Cardiol; 2005; 26(1):56-61. PubMed ID: 14994183
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A contemporary comparison of the effect of shunt type in hypoplastic left heart syndrome on the hemodynamics and outcome at Fontan completion.
    Ballweg JA; Dominguez TE; Ravishankar C; Gaynor JW; Nicolson SC; Spray TL; Tabbutt S
    J Thorac Cardiovasc Surg; 2010 Sep; 140(3):537-44. PubMed ID: 20723722
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Modified Fontan procedure on 106 cases: indication and surgical results].
    Imai Y; Kurosawa H; Fukuchi S; Ishihara K; Sawatari K; Kawada M; Matsuo K; Seo K; Terada M; Takeuchi K
    Rinsho Kyobu Geka; 1989 Apr; 9(2):133-7. PubMed ID: 9301908
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intermediate term thrombotic risk in contemporary total cavo-pulmonary connection for single ventricle circulations.
    Faircloth JM; Roe O; Alsaied T; Palumbo JS; Vinks A; Veldtman GR
    J Thromb Thrombolysis; 2017 Oct; 44(3):275-280. PubMed ID: 28761995
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Utility of the Total Thrombus-Formation Analysis System as a Tool for Evaluating Thrombogenicity and Monitoring Antithrombotic Therapy in Pediatric Fontan Patients.
    Matsuo O; Ishii M; Kaikita K; Morinaga J; Miyamura F; Matsumoto S; Tsujita K; Nakamura K
    Pediatr Cardiol; 2023 Jun; 44(5):1150-1159. PubMed ID: 36550317
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Early Thromboprophylaxis Initiation is Associated With Reduced Fontan Thromboses in the Early Postoperative Period.
    Ankola AA; Anderson BR; Choudhury TA; Rochelson E; Corda R; Bacha EA; Smerling AJ
    Semin Thorac Cardiovasc Surg; 2021; 33(3):806-813. PubMed ID: 33444768
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevalence and outcome of thrombotic and embolic complications in adults after Fontan operation.
    Egbe AC; Connolly HM; Niaz T; Yogeswaran V; Taggart NW; Qureshi MY; Poterucha JT; Khan AR; Driscoll DJ
    Am Heart J; 2017 Jan; 183():10-17. PubMed ID: 27979032
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Thrombotic and Embolic Complications Associated With Atrial Arrhythmia After Fontan Operation: Role of Prophylactic Therapy.
    Egbe AC; Connolly HM; McLeod CJ; Ammash NM; Niaz T; Yogeswaran V; Poterucha JT; Qureshi MY; Driscoll DJ
    J Am Coll Cardiol; 2016 Sep; 68(12):1312-9. PubMed ID: 27634123
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Thromboprophylaxis strategies for children with single-ventricle circulations (superior or total cavo-pulmonary connections) after stent implantation.
    Ooi YK; Ligon RA; Kelleman M; Vincent RN; Bauser-Heaton HD; Kim DW; Petit CJ
    Cardiol Young; 2019 Jul; 29(7):877-884. PubMed ID: 31208476
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Multiorgan malfunction after Fontan operation in adult patients].
    Smaś-Suska M; Iwaszczuk P; Róg B; Weryński P; Olszowska M; Podolec P; Tomkiewicz-Pająk L
    Pol Merkur Lekarski; 2017 Oct; 43(256):163-167. PubMed ID: 29084189
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nephropathy in patients after Fontan palliation.
    Anne P; Du W; Mattoo TK; Zilberman MV
    Int J Cardiol; 2009 Feb; 132(2):244-7. PubMed ID: 18234362
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long-term outcomes after first-onset arrhythmia in Fontan physiology.
    Carins TA; Shi WY; Iyengar AJ; Nisbet A; Forsdick V; Zannino D; Gentles T; Radford DJ; Justo R; Celermajer DS; Bullock A; Winlaw D; Wheaton G; Grigg L; d'Udekem Y
    J Thorac Cardiovasc Surg; 2016 Nov; 152(5):1355-1363.e1. PubMed ID: 27751239
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bosentan Therapy in a Patient with Failed Fontan Procedure: A Case Report.
    Lu T; Tang M; Wu Z; Huang C
    Heart Surg Forum; 2019 May; 22(3):E213-E214. PubMed ID: 31237545
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of the extracardiac conduit modification of the Fontan operation for thrombus formation using magnetic resonance imaging.
    Takawira F; Ayer JG; Onikul E; Hawker RE; Kemp A; Nicholson IA; Sholler GF
    Heart Lung Circ; 2008 Oct; 17(5):407-10. PubMed ID: 18403261
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bleeding and thrombotic risk in pregnant women with Fontan physiology.
    Girnius A; Zentner D; Valente AM; Pieper PG; Economy KE; Ladouceur M; Roos-Hesselink JW; Warshak C; Partington SL; Gao Z; Ollberding N; Faust M; Girnius S; Kaemmerer H; Nagdyman N; Cohen S; Canobbio M; Akagi T; Grewal J; Bradley E; Buber Y; Palumbo J; Walker N; Aboulhosn J; Oechslin E; Baumgartner H; Kurdi W; Book WM; Mulder BJM; Veldtman GR
    Heart; 2021 Sep; 107(17):1390-1397. PubMed ID: 33234672
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dosing Regimen Prediction and Confirmation With Rivaroxaban for Thromboprophylaxis in Children After the Fontan Procedure: Insights From the Phase III UNIVERSE Study.
    Zhu P; Willmann S; Zhou W; Yang H; Michelson AD; McCrindle BW; Li JS; Harris KC; Pina LM; Weber T; Nessel K; Lesko LJ; Kubitza D; Zannikos P
    J Clin Pharmacol; 2022 Feb; 62(2):220-231. PubMed ID: 34524700
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Coagulation and Anticoagulation in Fontan Patients.
    Heidendael JF; Engele LJ; Bouma BJ; Dipchand AI; Thorne SA; McCrindle BW; Mulder BJM
    Can J Cardiol; 2022 Jul; 38(7):1024-1035. PubMed ID: 35122939
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.